Currency in USD
| Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.78 | 0.67 | 1.9 | 3.13 |
| Low estimate | 0.74 | 0.46 | 1.86 | 2.62 |
| High estimate | 0.82 | 0.87 | 1.95 | 3.65 |
| Year ago EPS | 3.67 | 2.77 | 9.1 | 1.9 |
| Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 168.9M | 175.1M | 694.35M | 755.75M |
| Low estimate | 165.4M | 155.6M | 658.3M | 744.5M |
| High estimate | 172.4M | 194.6M | 730.4M | 767M |
| Year ago sales | 348.98M | 296.19M | 1.07B | 694.35M |
| Sales growth (year/est) | -51.60% | -40.90% | -35.20% | 8.80% |
| Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
|---|
| Est. EPS | 2.4 | 1.44 | 1.06 | 0.96 |
| Actual EPS | 3.67 | 2.77 | 2.12 | 0.55 |
| Difference | 1.27 | 1.33 | 1.06 | -0.41 |
| Surprise % | 52.90% | 92.40% | 100.00% | -42.70% |
| EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | 0.78 | 0.67 | 1.9 | 3.13 |
| 7 days ago | 0.78 | 0.67 | 1.9 | 3.13 |
| 30 days ago | 0.78 | 0.67 | 1.9 | 3.13 |
| 60 days ago | 1.49 | 1.43 | 5.04 | 6.13 |
| 90 days ago | 1.53 | 1.44 | 5.36 | 6.13 |
| EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | MED | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | -78.70% | N/A | N/A | N/A |
| Next qtr. | -75.80% | N/A | N/A | N/A |
| Current year | -79.10% | N/A | N/A | N/A |
| Next year | 64.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | 20.00% | N/A | N/A | N/A |
| Past 5 years (per annum) | 10.30% | N/A | N/A | N/A |
